L. P. H. Helmich, M. A. M. de Arruda, and M. T. Sapienza, “PSMA-directed radioligand therapy (PSMA-RLT) with Lutetium-177 (177Lu-PSMA) as a treatment to metastatic resistant prostate cancer: a systematic review”, Rev. Med. (São Paulo), vol. 100, no. 4, pp. 391–402, Oct. 2021, doi: 10.11606/issn.1679-9836.v100i4p391-402.